"10.1371_journal.pone.0060852","plos one","2013-04-09T00:00:00Z","Samir K Gupta; Deming Mi; Michael P Dub√©; Chandan K Saha; Raymond M Johnson; James H Stein; Matthias A Clauss; Kieren J Mather; Zeruesenay Desta; Ziyue Liu","Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Division of Infectious Diseases, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America; Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America; Department of Cellular & Integrative Physiology, Center for Vascular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Division of Endocrinology & Metabolism, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America","Conceived and designed the experiments: SKG MPD CKS RMJ MAC KJM ZD. Performed the experiments: SKG JHS ZD. Analyzed the data: SKG DM MPD CKS JHS KJM ZD ZL. Contributed reagents/materials/analysis tools: DM CKS JHS ZD ZL. Wrote the paper: SKG DM MPD CKS RMJ JHS MAC KJM ZL.","SKG reports having received unrestricted research grant support from Gilead Sciences, Inc., Merck & Co., and Janssen (Tibotec) Therapeutics and receives consultant fees from Bristol-Myers Squibb. MPD reports having received research grant support from ViiV Healthcare/GlaxoSmithKline and grant support from Serono. CKS reports having received statistical consulting fees from Merck & Co. and serves on a Data and Safety Monitoring Committee for Merck & Co. JHS serves on the Data and Safety Monitoring Committees for Abbott, Lilly, and Takeda. KJM reports having received research support for unrelated projects from Merck & Co. All other authors have declared that no competing interests exist. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Samir K Gupta","SKG",10,FALSE,7,3,8,9,TRUE,TRUE,FALSE,0,NA,FALSE
